Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Earning money while studying is possible with the right strategies. Explore various ways to balance work and academics.
27,524 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Nexchain has launched a six-day limited-time $0.05 bonus window ahead of a scheduled project update. The move signals...
Nvidia trades at a clear premium as AI demand drives semiconductors higher, while Adobe sits at a comparatively modes...
Investors dig into a mixed session as Amazon leads gains on Prime Day momentum and AI shopping activity. This guide b...
What would it take for Micron Technology stock to run from here to a life-changing level in a year? This article lays...
Meta faced a pivotal near-miss in 2026 as it stepped back from a Kalshi deal. The decision highlights how regulatory ...
As the first half 2026 over wraps up, AI stocks show a rotating leadership. This article highlights two compelling be...
Sberbank plans a crypto wallet and digital depository within its app ecosystem by December, a move aimed at bringing ...
A veteran Jefferies strategist outlines a split AI spend cycle: upfront hardware capex drives early gains, while long...
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
The Magnificent Seven have long led the market, but their valuations have cooled. Explore the three biggest bargain p...
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...